Should We Perform Imaging-Guided Lymph Node Dissection in Patients with Lymphatic Recurrence of Prostate Cancer after Radical Prostatectomy?

European Urology

Volumn 55, Issue 6, 2009, Pages 1302-1304

  Martorana, Giuseppe ^a   Schiavina, Riccardo ^a   Franceschelli, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID C 11; ANTINEOPLASTIC AGENT; CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN;

CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; DRUG EFFICACY; EDITORIAL; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC SYSTEM; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

DIAGNOSTIC IMAGING; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 65049083635     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.08.011     Document Type: Editorial

References (10)

1. Makarov D.V., Humphreys E.B., Mangold L.A., et al. The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy. J Urol 179 (2008) 156-161
2. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
3. Picchio M., Messa M., Landoni C., et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucosepositron emission tomography. J Urol 169 (2003) 1337-1340
4. 11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 52 (2007) 423-429
5. Schilling D., Schlemmer H.P., Wagner P.H., et al. Histological verification of 11 C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int 102 (2008) 446-451
6. Masterson T.A., Bianco Jr. F.J., Vickers A.J., et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 175 (2006) 1320-1324
7. Bader P., Burkhard F.C., Markwalder R., et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169 (2003) 849-854
8. Schumacher M.C., Burkhard F.C., Thalmann G.N., Fleischmann A., and Studer U.E. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 54 (2008) 344-352
9. Daneshmand S., Quek M.L., Stein J.P., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172 (2004) 2252-2255
10. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 54 (2008) 392-401